相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer
Sergio Marchini et al.
EUROPEAN JOURNAL OF CANCER (2013)
Chemoresistance to 5-fluorouracil induces epithelial-mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells
Weijia Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition
Wei Zhu et al.
GUT (2012)
Targeting NFκB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2
James W. Antoon et al.
CANCER BIOLOGY & THERAPY (2011)
Notch Signaling Activated by Replication Stress-Induced Expression of Midkine Drives Epithelial-Mesenchymal Transition and Chemoresistance in Pancreatic Cancer
Cenap Guengoer et al.
CANCER RESEARCH (2011)
Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients
Li-Ru He et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations
Xiaoli Chen et al.
JOURNAL OF HEPATOLOGY (2011)
Integration of DNA Copy Number Alterations and Prognostic Gene Expression Signatures in Breast Cancer Patients
Hugo M. Horlings et al.
CLINICAL CANCER RESEARCH (2010)
Overexpression of Eukaryotic Initiation Factor 5A2 Enhances Cell Motility and Promotes Tumor Metastasis in Hepatocellular Carcinoma
Dong-Jiang Tang et al.
HEPATOLOGY (2010)
Overexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder
Jun-Hang Luo et al.
CANCER SCIENCE (2009)
Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma
Guo-Fen Yang et al.
GYNECOLOGIC ONCOLOGY (2009)
Targeting oncogenes to improve breast cancer chemotherapy
LA Christensen et al.
CANCER RESEARCH (2006)
Pkc1 acts through Zds1 and Gic1 to suppress growth and cell polarity defects of a yeast eIF5A mutant
CF Zanelli et al.
GENETICS (2005)
Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma
PH Rao et al.
BMC CANCER (2004)
Identification of mRNA that binds to eukaryotic initiation factor 5A by affinity co-purification and differential display
AG Xu et al.
BIOCHEMICAL JOURNAL (2004)
Oncogenic role of eIF-5A2 in the development of ovarian cancer
XY Guan et al.
CANCER RESEARCH (2004)
Identification and characterization of eukaryotic initiation factor 5A-2
PMJ Clement et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patients
QJ He et al.
CANCER GENETICS AND CYTOGENETICS (2003)
Recurrent chromosome alterations in primary ovarian carcinoma in Chinese women
JST Sham et al.
CANCER GENETICS AND CYTOGENETICS (2002)
Human EIF5A2 an chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expression
ZA Jenkins et al.
GENOMICS (2001)
Recurrent chromosome changes in 62 primary gastric carcinomas detected by comparative genomic hybridization
XY Guan et al.
CANCER GENETICS AND CYTOGENETICS (2000)
A broad amplification pattern at 3q in squamous cell lung cancer -: A fluorescence in situ hybridization study
E Kettunen et al.
CANCER GENETICS AND CYTOGENETICS (2000)
分享论文
